Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-24-000639
Filing Date
2024-07-29
Accepted
2024-07-29 16:11:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2887
  Complete submission text file 0001968582-24-000639.txt   4409
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Subject) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40021 | Film No.: 241152465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 PARK PLAZA SUITE 1200 IRVINE CA 92614
Business Address
Grodnensky Oleg (Reporting) CIK: 0001843167 (see all company filings)

Type: 144